Skip to main content

Table 2 Genotype distributions of SNPs used in this study

From: Addition of host genetic variants in a prediction rule for post meningitis hearing loss in childhood: a model updating study

Genetic variables

Total *

Wildtype

Heterozygous

Mutant

 

N

%

N

%

n

%

n

%

TLR2-16934 T > A HL

32

94.1

7

21.9

15

46.9

10

31.3

TLR2-16934 T > A no HL

411

94.1

114

27.7

196

47.7

101

24.6

TLR2 + 2477 G > A HL

34

100

34

100

0

0

0

0

TLR2 + 2477 G > A no HL

430

98.4

382

88.8

46

10.7

2

0,5

TLR4 + 896 A > G HL

34

100

25

73.5

8

23.5

1

2.9

TLR4 + 896 A > G no HL

420

96.1

374

89.0

33

7.9

13

3.1

TLR9-1237 T > C HL

33

97.1

21

63.6

12

36.4

0

0

TLR9-1237 T > C no HL

430

98.4

320

74.4

101

23.5

9

2.1

TLR9 + 2848 G > A HL

33

97.1

5

15.2

16

48.5

12

36.4

TLR9 + 2848 G > A no HL

426

97.5

104

24.4

199

46.7

123

28.9

NOD1 + 32556 T > GG HL

34

100

20

58.8

13

38.2

1

2.9

NOD1 + 32556 T > GG no HL

414

94.7

239

57.7

148

35.7

27

6.5

NOD2 +2209 C > T HL

34

100

32

94.1

2

5.9

0

0

NOD2 +2209 C > T no HL

427

97.7

381

89.2

38

8.9

8

1.9

NOD2 +2722 G > C HL

31

91.2

31

100

0

0

0

0

NOD2 +2722 G > C no HL

421

96.3

410

97.4

8

1.9

3

0.7

NOD2 +3020 ins C HL

33

97.1

31

93.9

2

6.1

0

0

NOD2 +3020 ins C no HL

426

97.5

409

96.0

16

3.8

1

0.2

CASP1 + 8404 A > G HL

34

100

22

64.7

10

29.4

2

5.9

CASP1 + 8404 A > G no HL

433

99.11

258

59.6

145

33.5

30

6.9

TRAIL-692 T > C HL

33

97.1

26

78.8

6

18.2

1

3.0

TRAIL-692 T > C no HL

420

96.1

339

80.7

72

17.1

9

2.1

  1. *Genotypes and percentage of all included cases.
  2. Abbreviations:
  3. TLR: Toll-like receptor.
  4. HL: Hearing loss.
  5. NOD: Nucleotide oligomerization domain protein.
  6. CASP: Caspase.
  7. TRAIL: Tumour necrosis factor related apoptosis inducing ligand.